Ehealth Stock EBITDA

EHTH Stock

USD 3.21 0.19 5.59%

By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess EHealth's long-term financial health and intrinsic value.

		Last Reported	Projected for Next Year
	EBITDA	46.8 M	49.1 M

The EHealth's current EBITDA is estimated to increase to about 49.1 M.

Build AI portfolio with EHealth Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

eHealth Company EBITDA Analysis

EHealth's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current EHealth EBITDA

46.81 M

Most of EHealth's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, eHealth is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

EHealth EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for EHealth is extremely important. It helps to project a fair market value of EHealth Stock properly, considering its historical fundamentals such as EBITDA. Since EHealth's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EHealth's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EHealth's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Current Deferred Revenue	Net Debt	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Short Term Investments	Treasury Stock	Good Will	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Long Term Debt Total	Capital Stock
Total Assets		0.88	0.35	0.78	0.43	0.66	0.69	0.98	0.9	-0.18	0.64	0.75	0.38	0.97	0.64	-0.47	0.74	0.97	0.92	0.74	0.97	0.95	0.92	0.57
Total Stockholder Equity	0.88		0.5	0.4	0.6	0.37	0.51	0.86	0.97	-0.19	0.4	0.79	0.5	0.85	0.46	-0.49	0.42	0.79	0.91	0.76	0.91	0.91	0.9	0.76
Retained Earnings	0.35	0.5		0.02	0.23	0.23	0.55	0.41	0.38	-0.4	-0.2	0.42	0.4	0.34	0.63	-0.47	-0.25	0.19	0.26	0.76	0.44	0.23	0.37	0.0
Total Liab	0.78	0.4	0.02		0.01	0.82	0.67	0.77	0.5	-0.09	0.7	0.45	0.05	0.76	0.65	-0.26	0.88	0.85	0.64	0.47	0.68	0.63	0.65	0.08
Current Deferred Revenue	0.43	0.6	0.23	0.01		-0.04	0.01	0.42	0.57	0.01	-0.01	0.34	0.79	0.39	0.13	-0.21	0.0	0.32	0.47	0.31	0.45	0.58	0.43	0.67
Net Debt	0.66	0.37	0.23	0.82	-0.04		0.64	0.72	0.35	-0.31	0.46	0.3	0.03	0.68	0.7	-0.34	0.65	0.7	0.55	0.61	0.64	0.53	0.6	0.05
Accounts Payable	0.69	0.51	0.55	0.67	0.01	0.64		0.66	0.51	-0.02	0.27	0.51	0.26	0.75	0.81	-0.37	0.41	0.69	0.59	0.78	0.74	0.52	0.71	-0.09
Net Receivables	0.98	0.86	0.41	0.77	0.42	0.72	0.66		0.87	-0.29	0.61	0.74	0.37	0.94	0.68	-0.52	0.71	0.94	0.89	0.78	0.95	0.92	0.89	0.55
Total Current Assets	0.9	0.97	0.38	0.5	0.57	0.35	0.51	0.87		-0.12	0.52	0.83	0.45	0.85	0.44	-0.45	0.54	0.84	0.94	0.69	0.9	0.93	0.9	0.73
Short Term Debt	-0.18	-0.19	-0.4	-0.09	0.01	-0.31	-0.02	-0.29	-0.12		0.09	0.15	0.03	-0.1	-0.29	-0.16	-0.03	-0.13	-0.04	-0.3	-0.17	-0.12	-0.07	-0.11
Intangible Assets	0.64	0.4	-0.2	0.7	-0.01	0.46	0.27	0.61	0.52	0.09		0.57	-0.3	0.58	0.16	-0.37	0.77	0.71	0.57	0.2	0.52	0.59	0.5	0.36
Common Stock	0.75	0.79	0.42	0.45	0.34	0.3	0.51	0.74	0.83	0.15	0.57		0.33	0.7	0.44	-0.79	0.48	0.66	0.78	0.62	0.72	0.71	0.74	0.48
Property Plant Equipment	0.38	0.5	0.4	0.05	0.79	0.03	0.26	0.37	0.45	0.03	-0.3	0.33		0.36	0.41	-0.27	0.01	0.26	0.37	0.43	0.43	0.45	0.37	0.38
Long Term Debt	0.97	0.85	0.34	0.76	0.39	0.68	0.75	0.94	0.85	-0.1	0.58	0.7	0.36		0.64	-0.43	0.69	0.95	0.9	0.78	0.96	0.9	0.96	0.53
Short Term Investments	0.64	0.46	0.63	0.65	0.13	0.7	0.81	0.68	0.44	-0.29	0.16	0.44	0.41	0.64		-0.37	0.37	0.62	0.48	0.86	0.69	0.48	0.58	-0.07
Treasury Stock	-0.47	-0.49	-0.47	-0.26	-0.21	-0.34	-0.37	-0.52	-0.45	-0.16	-0.37	-0.79	-0.27	-0.43	-0.37		-0.24	-0.36	-0.44	-0.49	-0.46	-0.41	-0.41	-0.26
Good Will	0.74	0.42	-0.25	0.88	0.0	0.65	0.41	0.71	0.54	-0.03	0.77	0.48	0.01	0.69	0.37	-0.24		0.81	0.65	0.25	0.6	0.66	0.59	0.34
Net Tangible Assets	0.97	0.79	0.19	0.85	0.32	0.7	0.69	0.94	0.84	-0.13	0.71	0.66	0.26	0.95	0.62	-0.36	0.81		0.89	0.68	0.94	0.93	0.89	0.51
Capital Surpluse	0.92	0.91	0.26	0.64	0.47	0.55	0.59	0.89	0.94	-0.04	0.57	0.78	0.37	0.9	0.48	-0.44	0.65	0.89		0.69	0.92	0.94	0.95	0.64
Deferred Long Term Liab	0.74	0.76	0.76	0.47	0.31	0.61	0.78	0.78	0.69	-0.3	0.2	0.62	0.43	0.78	0.86	-0.49	0.25	0.68	0.69		0.85	0.67	0.79	0.28
Net Invested Capital	0.97	0.91	0.44	0.68	0.45	0.64	0.74	0.95	0.9	-0.17	0.52	0.72	0.43	0.96	0.69	-0.46	0.6	0.94	0.92	0.85		0.94	0.94	0.56
Net Working Capital	0.95	0.91	0.23	0.63	0.58	0.53	0.52	0.92	0.93	-0.12	0.59	0.71	0.45	0.9	0.48	-0.41	0.66	0.93	0.94	0.67	0.94		0.89	0.74
Long Term Debt Total	0.92	0.9	0.37	0.65	0.43	0.6	0.71	0.89	0.9	-0.07	0.5	0.74	0.37	0.96	0.58	-0.41	0.59	0.89	0.95	0.79	0.94	0.89		0.57
Capital Stock	0.57	0.76	0.0	0.08	0.67	0.05	-0.09	0.55	0.73	-0.11	0.36	0.48	0.38	0.53	-0.07	-0.26	0.34	0.51	0.64	0.28	0.56	0.74	0.57

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict EHealth

Ebitda Over Time

EHealth Ebitda

Ebitda

49.15 Million

As of now, EHealth's EBITDA is increasing as compared to previous years.

According to the company disclosure, eHealth reported earnings before interest,tax, depreciation and amortization of 46.81 M. This is 99.93% lower than that of the Insurance sector and 96.04% lower than that of the Financials industry. The ebitda for all United States stocks is 98.8% higher than that of the company.

EHealth EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EHealth's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EHealth could also be used in its relative valuation, which is a method of valuing EHealth by comparing valuation metrics of similar companies.

EHealth is currently under evaluation in ebitda category among its peers.

EHealth ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EHealth's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EHealth's managers, analysts, and investors.

Environmental

Governance

Social

EHealth Institutional Holders

Institutional Holdings refers to the ownership stake in EHealth that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of EHealth's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EHealth's value.

		Shares
Acadian Asset Management Llc	2025-03-31	445.9 K
Rbf Llc	2025-03-31	435.4 K
Renaissance Technologies Corp	2025-03-31	377.4 K
Two Sigma Advisers, Llc	2025-03-31	373.9 K
Geode Capital Management, Llc	2025-03-31	353.6 K
Two Sigma Investments Llc	2025-03-31	332.6 K
Morgan Stanley - Brokerage Accounts	2025-03-31	296.6 K
D. E. Shaw & Co Lp	2025-03-31	264.3 K
Ubs Group Ag	2025-03-31	245.5 K
Palo Alto Investors, Llc	2025-03-31	1.7 M
Vanguard Group Inc	2025-03-31	1.3 M

EHealth Fundamentals

	Return On Equity	0.0319
	Return On Asset	0.0277
	Profit Margin	0.05 %
	Operating Margin	0.04 %
	Current Valuation	385.39 M
	Shares Outstanding	30.33 M
	Shares Owned By Insiders	5.83 %
	Shares Owned By Institutions	74.13 %
	Number Of Shares Shorted	1.08 M
	Price To Earning	2.54 X
	Price To Book	0.17 X
	Price To Sales	0.18 X
	Revenue	532.41 M
	Gross Profit	550.77 M
	EBITDA	46.81 M
	Net Income	10.06 M
	Cash And Equivalents	164.75 M
	Cash Per Share	6.01 X
	Total Debt	96.92 M
	Debt To Equity	0.12 %
	Current Ratio	10.36 X
	Book Value Per Share	19.37 X
	Cash Flow From Operations	(18.37 M)
	Short Ratio	2.27 X
	Earnings Per Share	(0.56) X
	Price To Earnings To Growth	0.72 X
	Target Price	10.0
	Number Of Employees	1.77 K
	Beta	0.97
	Market Capitalization	97.35 M
	Total Asset	1.16 B
	Retained Earnings	15.25 M
	Working Capital	258.46 M
	Current Asset	77.54 M
	Current Liabilities	31.94 M
	Net Asset	1.16 B

About EHealth Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze eHealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EHealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of eHealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

USOI	Credit Suisse X Links
ULTY	Tidal Trust II
CONY	YieldMax N Option
BCAT	BlackRock Capital Allocation
PDI	Pimco Dynamic Income

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:

How To Invest In EHealth

Details

Is EHealth Stock a good investment?

Details

What is EHealth's Net Worth?

Details

Largest Insurance Brokers Companies

View

Largest Financial Services Companies

View

Check out EHealth Piotroski F Score and EHealth Altman Z Score analysis.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.976

Earnings Share

(0.56)

Revenue Per Share

18.664

Quarterly Revenue Growth

0.217

Return On Assets

0.0277

The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Ehealth Stock EBITDA

eHealth Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current EHealth EBITDA

EHealth EBITDA Driver Correlations

EHealth Ebitda

Ebitda

49.15 Million

EHealth EBITDA Peer Comparison

EHealth ESG Sustainability

EHealth Institutional Holders

EHealth Fundamentals

About EHealth Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY